3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Breast Neoplasms
9
Lung Neoplasms
8
Hematologic Neoplasms
5
Colorectal Neoplasms
5
Prostatic Neoplasms
4
Hodgkin Disease
4
Carcinoma, Non-Small-Cell Lung
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Motor Activity
3
Pancreatic Neoplasms
2
Obesity
2
Neoplasms
2
Multiple Myeloma
2
Lymphoma, Non-Hodgkin
2
Hematopoietic and Lymphoid System Neoplasm
2
Gastrointestinal Diseases
2
Cardiotoxicity
2
Urinary Bladder Neoplasms
1
Trastuzumab Cardiotoxicity
1
Small Cell Lung Carcinoma
1
Sedentary Behavior
1
Sarcopenia
1
Polycystic Ovary Syndrome
1
Pelvic Neoplasms
1
Pathologically Proven Gastrointestinal Malignancy
1
Oropharyngeal Neoplasms
1
Neoplasm Metastasis
1
Myocardial Fibrosis
1
Myelodysplastic Syndromes
1
Multiple Endocrine Neoplasia Type 1
1
Interventions
Radiosurgery
79
Capecitabine
77
Oxaliplatin
74
Fluorouracil
69
Bevacizumab
69
Gemcitabine
67
Leucovorin
61
pembrolizumab
53
Nivolumab
53
Paclitaxel
48
Irinotecan
47
Radiotherapy
45
Cisplatin
44
Everolimus
38
Magnetic Resonance Spectroscopy
36
Drug Therapy
36
Docetaxel
36
Cyclophosphamide
35
Cetuximab
35
Ipilimumab
32
Carboplatin
32
Trastuzumab
31
Sunitinib
30
Sorafenib
26
Erlotinib Hydrochloride
25
Doxorubicin
23
Surveys and Questionnaires
20
Surgical Procedures, Operative
20
Specimen Handling
20
Biopsy
19
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Neoplasm Metastasis
×
Exercise Test
×
Clear all
NCT04676009
2024-02-21
ERICA
Centre Leon Berard
Phase NA
Completed
26 enrolled